Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Mershon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Obstetrics and Gynecology|May 16, 2003
Estrogen increases inducible nitric oxide synthase gene expressionLeigh S Walsh, Arthur Ollendorff, John L Mershon
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2002
Estrogen increases iNOS expression in the ovine coronary arteryJohn L Mershon, R Scott Baker, Kenneth E Clark
The Journal of Reproductive Medicine|June 24, 2005
Association of leptin with poor ovarian stimulation during in vitro fertilizationJared C Robins, Rashmi Srivastava, John L Mershon, et al.
Clinical Breast Cancer|March 21, 2009
Incidence of invasive breast cancer in postmenopausal women after discontinuation of long-term raloxifene administrationVictor G Vogel, Yongming Qu, Mayme Wong, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 7, 2006
Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheepWillie D Zoma, R Scott Baker, John L Mershon, et al.
Breast Cancer Research and Treatment|October 10, 2006
Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factorsJane A Cauley, Jingli Song, Sherie A Dowsett, et al.
Current Medical Research and Opinion|October 4, 2005
Safety assessment of raloxifene over eight years in a clinical trial settingSilvana Martino, Damon Disch, Sherie A Dowsett, et al.
American Journal of Obstetrics and Gynecology|December 26, 2002
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovineWillie D Zoma, R Scott Baker, Gideon Kopernik, et al.
Menopause (New York, N.Y.)|April 21, 2011
Compliance with mammography and bone mineral density screening in women at least 50 years oldEric S Meadows, Albert Whangbo, Neil McQuarrie, et al.
Current Medical Research and Opinion|September 17, 2010
Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitoninShonda A Foster, Albert Whangbo, Beth Mitchell, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|May 16, 2003
Estrogen increases inducible nitric oxide synthase gene expressionLeigh S Walsh, Arthur Ollendorff, John L Mershon
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2002
Estrogen increases iNOS expression in the ovine coronary arteryJohn L Mershon, R Scott Baker, Kenneth E Clark
The Journal of Reproductive Medicine|June 24, 2005
Association of leptin with poor ovarian stimulation during in vitro fertilizationJared C Robins, Rashmi Srivastava, John L Mershon, et al.
Clinical Breast Cancer|March 21, 2009
Incidence of invasive breast cancer in postmenopausal women after discontinuation of long-term raloxifene administrationVictor G Vogel, Yongming Qu, Mayme Wong, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 7, 2006
Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheepWillie D Zoma, R Scott Baker, John L Mershon, et al.
Breast Cancer Research and Treatment|October 10, 2006
Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factorsJane A Cauley, Jingli Song, Sherie A Dowsett, et al.
Current Medical Research and Opinion|October 4, 2005
Safety assessment of raloxifene over eight years in a clinical trial settingSilvana Martino, Damon Disch, Sherie A Dowsett, et al.
American Journal of Obstetrics and Gynecology|December 26, 2002
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovineWillie D Zoma, R Scott Baker, Gideon Kopernik, et al.
Menopause (New York, N.Y.)|April 21, 2011
Compliance with mammography and bone mineral density screening in women at least 50 years oldEric S Meadows, Albert Whangbo, Neil McQuarrie, et al.
Current Medical Research and Opinion|September 17, 2010
Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitoninShonda A Foster, Albert Whangbo, Beth Mitchell, et al.
Pageof 2